PMC:7212949 / 9603-9796 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T40","span":{"begin":34,"end":39},"obj":"Body_part"},{"id":"T41","span":{"begin":99,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"• Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T36","span":{"begin":34,"end":39},"obj":"Body_part"},{"id":"T37","span":{"begin":99,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A36","pred":"uberon_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A37","pred":"uberon_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"• Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T58","span":{"begin":34,"end":39},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T59","span":{"begin":99,"end":103},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T60","span":{"begin":99,"end":103},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"• Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease"}

{"project":"LitCovid-sentences","denotations":[{"id":"T160","span":{"begin":23,"end":50},"obj":"Sentence"},{"id":"T161","span":{"begin":51,"end":93},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1676","span":{"begin":139,"end":141},"obj":"GO:0016265"},{"id":"T1677","span":{"begin":158,"end":161},"obj":"UBERON:0001987"},{"id":"T122","span":{"begin":99,"end":103},"obj":"UBERON:0002048"},{"id":"T572","span":{"begin":31,"end":39},"obj":"SP_7"},{"id":"T573","span":{"begin":72,"end":86},"obj":"CL:1000488"},{"id":"T574","span":{"begin":98,"end":105},"obj":"UBERON:0002294"},{"id":"T575","span":{"begin":106,"end":115},"obj":"UBERON:0000483"},{"id":"T576","span":{"begin":142,"end":152},"obj":"GO:0010467"},{"id":"T577","span":{"begin":156,"end":160},"obj":"G_3;PG_10;PR:000003622"}],"text":"• Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease"}